Comparison of high-risk patients identified by the original risk stratification methods and by incorporating a 1.5 multiplier according to European League Against Rheumatism (EULAR) task force recommendations
| Original definition of risk algorithms applied to total eligible population | Original definition of risk algorithms applied to patients eligible according to EULAR task force recommendations | Risk algorithms multiplied by 1.5, applied to patients eligible according to EULAR task force recommendations | |
|---|---|---|---|
| FRS | 5/ 266 (1.6%) | 2/131 (1.5%) | 9/131 (6.9%) |
| NCEP | 64/294 (21.7%) | 28/144 (19.4%) | 34/144 (23.6%) |
| SCORE (TC:HDL ratio) | 43/166 (25.9%) | 13/73 (17.8%) | 16/73 (21.9%) |
| Reynolds Risk Score | 45/291 (15.5%) | 20/140 (14.3%) | 40/140 (28.6%) |
Risk multiplication (1.5-fold selection): the EULAR task force recommendations are a 1.5 multiplier applied to all patients for two out of three criteria, a disease duration ≥10 years and seropositive result or evidence of extra-articular disease.
FRS, Framingham Risk Score; NCEP, National Cholesterol Education Program; SCORE (TC:HDL ratio): systematic coronary risk evaluation according to total cholesterol:high density lipoprotein ratio tables.